ser
el
bocaviru
humano
un
agent
causal
de
parotid
en
dear
editor
parot
usual
associ
mump
viral
infect
sinc
trival
measlesmumpsrubella
vaccin
start
administr
differ
countri
burden
diseas
steadili
reduc
nowaday
parot
case
usual
relat
viral
infect
countri
high
vaccin
coverag
although
epstein
barr
viru
ebv
recogn
frequent
detect
microorgan
respiratori
virus
parainfluenza
viru
piv
adenoviru
describ
associ
parot
human
bocaviru
hbov
identifi
respiratori
infect
children
larg
number
studi
mainli
infant
less
year
age
late
autumn
recurr
wheez
episod
fever
frequent
symptomatolog
date
two
case
parot
report
associ
bocaviru
infect
one
coinfect
piv
two
case
detect
two
prospect
studi
survey
frequenc
sever
virus
sporad
parot
korea
usa
author
observ
incid
hbov
infect
studi
case
report
child
parot
acut
respiratori
tract
infect
hbov
viru
identifi
male
histori
recurr
wheez
present
emerg
room
novemb
h
left
parotid
swell
fever
hour
maximum
c
respiratori
distress
improv
despit
receiv
bronchodil
amoxicillinclavulan
two
day
physic
examin
reveal
high
fever
left
parotid
inflamm
without
erythema
expiratori
wheez
hypoxaemia
requir
admiss
treatment
bronchodil
oxygen
therapi
chest
xray
demonstr
infiltr
right
middl
lobe
cervic
ultrasound
reveal
enlarg
left
parotid
gland
multipl
intern
lesion
low
echogen
relat
intraglandular
inflammatori
chang
intraglandular
adenopathi
bilater
laterocerv
chain
also
observ
blood
test
show
normal
haemoglobin
platelet
leukocyt
neutrophil
creactiv
protein
mgl
amylas
ul
blood
cultur
neg
multiplex
polymeras
chain
reaction
nasopharyng
aspir
taken
admiss
clart
pneumovir
array
assay
identifi
adenoviru
metapneumoviru
b
parinfluenza
rhinoviru
respiratori
syncyti
viru
b
bocaviru
influenza
b
c
enteroviru
coronaviru
posit
hbov
mump
serolog
detect
neg
igm
posit
igg
titr
remain
afebril
admiss
improv
respiratori
distress
disappear
parotid
swell
discharg
within
day
two
week
admiss
patient
asymptomat
cervic
ultrasound
normal
except
intraparotid
adenopathi
amylas
titr
ul
control
nasopharyng
aspir
moment
neg
human
bocaviru
associ
lower
respiratori
tract
infect
mainli
wheez
pneumonia
young
children
also
describ
caus
agent
upper
respiratori
tract
infect
mainli
adenoid
otiti
demonstr
affin
type
tissu
date
two
case
hbov
associ
mump
pathogen
role
caus
agent
parot
discuss
sinc
one
case
detect
coinfect
piv
howev
parotid
gland
could
target
infect
viru
occur
adenoid
author
identifi
hbov
specimen
obtain
children
adenoid
diseas
patient
typic
symptomatolog
associ
hbov
infect
wheez
episod
infiltr
chest
xray
addit
frequent
agerang
viru
infect
develop
diseas
late
autumn
hbov
infect
occur
analyt
data
also
consist
describ
hbov
infect
bacteri
agent
detect
correctli
vaccin
mump
serolog
show
presenc
igg
titr
acut
ebv
infect
also
rule
clinic
pictur
evolv
favour
nasopharyng
aspir
control
neg
two
week
acut
episod
although
causal
hbov
difficult
establish
serolog
demonstr
hbov
pathogen
role
respiratori
infect
unfortun
centr
hbov
serolog
avail
think
case
add
alreadi
describ
make
consid
may
etiolog
role
consid
hbov
taken
consider
infrequ
possibl
caus
agent
acut
parot
young
children
prospect
studi
design
verifi
truli
pathogen
role
parot
case
dear
editor
pleural
tuberculosi
pt
signific
caus
tuberculosi
tb
region
castil
along
genitourinari
tuberculosi
common
caus
extrapulmonari
tb
respect
posit
cultur
mycobacterium
tuberculosi
mt
proport
posit
cultur
pleural
fluid
pf
rang
number
case
pt
remain
around
annual
case
confirm
cultur
time
decreas
number
case
pulmonari
tb
previou
studi
conduct
bierzo
health
board
area
reveal
pf
sampl
posit
mt
cultur
view
situat
decid
look
system
select
pf
sampl
improv
perform
mycobacteri
cultur
optimis
use
molecular
techniqu
sampl
assess
total
pf
sampl
collect
adenosin
deaminas
ada
valu
determin
sampl
establish
cutoff
point
ul
pt
suspect
health
board
area
sampl
seed
solid
cultur
media
coletso
middlebrook
autom
liquid
media
bactalert
mp
incub
least
week
ada
found
cutoff
point
autom
liquid
medium
reseed
end
incub
period
incub
bottl
prolong
least
three
week
pf
rate
growthdetect
pcr
increas
case
shown
tabl
doubt
pleural
effus
predominantli
lymphocyt
sampl
figur
rang
mt
growth
obtain
solid
media
two
case
two
three
coloni
grew
first
six
week
incub
growth
mt
liquid
media
occur
four
case
mean
day
growth
neg
two
case
mt
growth
obtain
pf
sampl
ada
valu
ul
accord
recent
review
method
determin
ada
valu
establish
cutoff
point
adapt
region
high
tb
rate
high
discriminatori
power
contrast
lowincid
region
would
high
neg
predict
valu
main
disput
factor
determin
cutoff
point
enabl
differenti
tb
process
vari
wide
accord
follow
paramet
preval
tb
geograph
area
studi
age
patient
patient
cutoff
point
would
drop
iul
would
rise
iul
number
case
studi
studi
case
pleural
effus
duli
classifi
accord
aetiolog
mean
age
mean
cutoff
point
set
iu
valu
iul
relat
lymphoprolif
process
carcinoma
paramalign
effus
empyema
averag
incid
tb
castil
case
per
popul
averag
incid
pt
case
per
popul
provinc
especi
counti
bierzo
continu
area
highest
incid
tb
region
select
pf
sampl
tb
detect
could
establish
initi
use
ada
accompani
marker
particularli
percentag
lymphocyt
biochem
paramet
would
need
start
studi
larger
number
sampl
order
determin
appropri
cutoff
point
health
area
studi
use
iul
cutoff
point
would
miss
two
case
pleural
fluid
tend
paucibacillari
sampl
greater
sensit
would
rais
limit
microbiolog
molecular
detect
view
fact
pf
sampl
studi
ada
valu
iul
alon
would
enabl
us
select
remain
ada
iul
applic
microbiolog
andor
molecular
techniqu
obtain
higher
diagnost
yield
cost
save
base
preliminari
result
absenc
exhaust
studi
conclud
use
molecular
techniqu
detect
mt
pf
ada
valu
iul
appear
reason
area
